African Horse Sickness Treatment Market: Overview
African horse sickness (AHS) mainly affects equine species; it is a mild or acute infection and is noncontagious. This disease is caused due to the virus African Horse Sickness Virus (AFSV). African horse sickness can cause a huge death rate in the horses as they are more susceptible to the disease, while mules have fewer chances of contracting the disease, and donkeys are excluded.
African Horse Sickness Treatment Market: Segmentation
The market for the African horse sickness treatment is globally fragmented into clinical forms and diagnosis. Based on the clinical forms, the global market is segregated into Dikkop or cardiac form, horse sickness fever, Dunkop or pulmonary form, and mixed form. Based on the diagnosis, the market is categorized into prevention treatment and diagnostic tests. The prevention treatment is sub-segmented into vaccines. The diagnostic tests can be further sub-categorized into laboratory tests for viral antigens and serological tests. The laboratory tests for viral antigens segment is further divided into reverse-transcription PCR assays and enzyme-linked immunosorbent assays.
African Horse Sickness Treatment Market: Growth Factors
For various preventive vaccines in the research and development activities, African horse sickness treatment (AHS) market will prove beneficial thus contributing to the growth of the market. The main factor that has driven the African horse sickness treatment market across all the regions is the existence of the standard operating procedures and the guidelines for the African horse sickness disease. The factor that is limiting the growth of the market is that even though the modified-live, multivalent vaccine is given to the horses they do not guarantee that the horses are completely protected from the African horse sickness but only the probability of the horse acquiring this disease decreases.
African Horse Sickness Treatment Market: Regional Analysis
Regional diversification of the African horse sickness treatment market is given as follows the Middle East & Africa, Eastern Europe, Asia Pacific, Latin America, Western Europe, and North America. Currently, the African horse sickness treatment market is dominated by the North America which is followed by Europe. The dominance of the North American region will continue in the coming years. In the North American region, United States Department of Agriculture (USDA) organization is present in the U.S. which deals with the standard operating procedures for the African horse sickness disease. European countries are also actively contributing to the market growth of African horse sickness treatment. The market will grow at a significant rate in Asia Pacific region owing to the emerging regional players in this region. The factors that attribute to the market growth in the Asia Pacific regions are developing healthcare infrastructure and rise in the awareness about the vaccination of the horses. The African horse sickness treatment market would be evolving at a significant rate across all the regions in the coming years.
African Horse Sickness Treatment Market: Competitive Players
The key market players that are involved in the African horse sickness treatment market include Veterinary Serum and Vaccine Research Institute and Onderstepoort Biological Products SOC Ltd.
African Horse Sickness Treatment Market: Regional Segment Analysis
What Reports Provides